Upregulated matrix metalloproteinase-2 and downregulated tissue factor pathway inhibitor-2 are risk factors for lymph node metastasis and perineural invasion in pancreatic carcinoma

Lu-Lu Zhai,1,2,* Yang Wu,1,2,* Chong-Yang Cai,1,2 Zhi-Gang Tang1,2 1Department of General Surgery, Affiliated Provincial Hospital, Anhui Medical University, 2Anhui Province Key Laboratory of Hepatopancreatobiliary Surgery, Hefei, People’s Republic of China *These authors contributed equa...

Full description

Bibliographic Details
Main Authors: Zhai LL, Wu Y, Cai CY, Tang ZG
Format: Article
Language:English
Published: Dove Medical Press 2015-10-01
Series:OncoTargets and Therapy
Online Access:https://www.dovepress.com/upregulated-matrix-metalloproteinase-2-and-downregulated-tissue-factor-peer-reviewed-article-OTT
id doaj-fb12dba282d24864957d31b772ba68bb
record_format Article
spelling doaj-fb12dba282d24864957d31b772ba68bb2020-11-25T01:36:45ZengDove Medical PressOncoTargets and Therapy1178-69302015-10-012015default2827283424036Upregulated matrix metalloproteinase-2 and downregulated tissue factor pathway inhibitor-2 are risk factors for lymph node metastasis and perineural invasion in pancreatic carcinomaZhai LLWu YCai CYTang ZGLu-Lu Zhai,1,2,* Yang Wu,1,2,* Chong-Yang Cai,1,2 Zhi-Gang Tang1,2 1Department of General Surgery, Affiliated Provincial Hospital, Anhui Medical University, 2Anhui Province Key Laboratory of Hepatopancreatobiliary Surgery, Hefei, People’s Republic of China *These authors contributed equally to this work Background: Dysregulated expression of matrix metalloproteinase (MMP)-2 and tissue factor pathway inhibitor (TFPI)-2 is closely associated with tumorigenesis and tumor progression. The aim of this work was to determine the predictive values of MMP-2 and TFPI-2 in identifying lymph node metastasis (LNM) and perineural invasion (PNI) in pancreatic carcinoma.Methods: Formalin-fixed and paraffin-embedded tissue samples containing pancreatic carcinoma tissues and their corresponding para-carcinoma tissues were obtained from 122 patients with pancreatic carcinoma. The expression levels of MMP-2 and TFPI-2 were evaluated by immunohistochemistry. The roles of MMP-2 and TFPI-2 in predicting LNM and PNI in pancreatic carcinoma were analyzed.Results: The level of MMP-2 expression was markedly increased in pancreatic carcinoma tissues (76.9%) compared with para-carcinoma tissues (29.2%; P<0.05). In contrast, there was obviously decreased TFPI-2 expression level in pancreatic carcinoma tissues (29.2%) compared with para-carcinoma tissues (77.7%; P<0.001). Additionally, MMP-2 expression was significantly positively correlated with LNM (r=0.468, P<0.01) and PNI (r=0.637, P<0.01). In contrast, TFPI-2 expression was strongly negatively correlated with LNM (r=-0.396, P<0.001) and PNI (r=-0.460, P<0.001). Logistic regression analysis showed that high MMP-2 expression and low TFPI-2 expression acted as independent predictors for LNM and PNI in pancreatic carcinoma.Conclusion: Taken together, our findings suggest that upregulated MMP-2 and downregulated TFPI-2 serve as useful predictors for a high risk of LNM and PNI. Obtaining information on the expression of MMP-2 and TFPI-2 before surgery may predict the occurrence of LNM and PNI, thereby permitting reasonable and effective surgical treatment for patients with pancreatic carcinoma. Keywords: MMP-2, TFPI-2, immunohistochemistryhttps://www.dovepress.com/upregulated-matrix-metalloproteinase-2-and-downregulated-tissue-factor-peer-reviewed-article-OTT
collection DOAJ
language English
format Article
sources DOAJ
author Zhai LL
Wu Y
Cai CY
Tang ZG
spellingShingle Zhai LL
Wu Y
Cai CY
Tang ZG
Upregulated matrix metalloproteinase-2 and downregulated tissue factor pathway inhibitor-2 are risk factors for lymph node metastasis and perineural invasion in pancreatic carcinoma
OncoTargets and Therapy
author_facet Zhai LL
Wu Y
Cai CY
Tang ZG
author_sort Zhai LL
title Upregulated matrix metalloproteinase-2 and downregulated tissue factor pathway inhibitor-2 are risk factors for lymph node metastasis and perineural invasion in pancreatic carcinoma
title_short Upregulated matrix metalloproteinase-2 and downregulated tissue factor pathway inhibitor-2 are risk factors for lymph node metastasis and perineural invasion in pancreatic carcinoma
title_full Upregulated matrix metalloproteinase-2 and downregulated tissue factor pathway inhibitor-2 are risk factors for lymph node metastasis and perineural invasion in pancreatic carcinoma
title_fullStr Upregulated matrix metalloproteinase-2 and downregulated tissue factor pathway inhibitor-2 are risk factors for lymph node metastasis and perineural invasion in pancreatic carcinoma
title_full_unstemmed Upregulated matrix metalloproteinase-2 and downregulated tissue factor pathway inhibitor-2 are risk factors for lymph node metastasis and perineural invasion in pancreatic carcinoma
title_sort upregulated matrix metalloproteinase-2 and downregulated tissue factor pathway inhibitor-2 are risk factors for lymph node metastasis and perineural invasion in pancreatic carcinoma
publisher Dove Medical Press
series OncoTargets and Therapy
issn 1178-6930
publishDate 2015-10-01
description Lu-Lu Zhai,1,2,* Yang Wu,1,2,* Chong-Yang Cai,1,2 Zhi-Gang Tang1,2 1Department of General Surgery, Affiliated Provincial Hospital, Anhui Medical University, 2Anhui Province Key Laboratory of Hepatopancreatobiliary Surgery, Hefei, People’s Republic of China *These authors contributed equally to this work Background: Dysregulated expression of matrix metalloproteinase (MMP)-2 and tissue factor pathway inhibitor (TFPI)-2 is closely associated with tumorigenesis and tumor progression. The aim of this work was to determine the predictive values of MMP-2 and TFPI-2 in identifying lymph node metastasis (LNM) and perineural invasion (PNI) in pancreatic carcinoma.Methods: Formalin-fixed and paraffin-embedded tissue samples containing pancreatic carcinoma tissues and their corresponding para-carcinoma tissues were obtained from 122 patients with pancreatic carcinoma. The expression levels of MMP-2 and TFPI-2 were evaluated by immunohistochemistry. The roles of MMP-2 and TFPI-2 in predicting LNM and PNI in pancreatic carcinoma were analyzed.Results: The level of MMP-2 expression was markedly increased in pancreatic carcinoma tissues (76.9%) compared with para-carcinoma tissues (29.2%; P<0.05). In contrast, there was obviously decreased TFPI-2 expression level in pancreatic carcinoma tissues (29.2%) compared with para-carcinoma tissues (77.7%; P<0.001). Additionally, MMP-2 expression was significantly positively correlated with LNM (r=0.468, P<0.01) and PNI (r=0.637, P<0.01). In contrast, TFPI-2 expression was strongly negatively correlated with LNM (r=-0.396, P<0.001) and PNI (r=-0.460, P<0.001). Logistic regression analysis showed that high MMP-2 expression and low TFPI-2 expression acted as independent predictors for LNM and PNI in pancreatic carcinoma.Conclusion: Taken together, our findings suggest that upregulated MMP-2 and downregulated TFPI-2 serve as useful predictors for a high risk of LNM and PNI. Obtaining information on the expression of MMP-2 and TFPI-2 before surgery may predict the occurrence of LNM and PNI, thereby permitting reasonable and effective surgical treatment for patients with pancreatic carcinoma. Keywords: MMP-2, TFPI-2, immunohistochemistry
url https://www.dovepress.com/upregulated-matrix-metalloproteinase-2-and-downregulated-tissue-factor-peer-reviewed-article-OTT
work_keys_str_mv AT zhaill upregulatedmatrixmetalloproteinase2anddownregulatedtissuefactorpathwayinhibitor2areriskfactorsforlymphnodemetastasisandperineuralinvasioninpancreaticcarcinoma
AT wuy upregulatedmatrixmetalloproteinase2anddownregulatedtissuefactorpathwayinhibitor2areriskfactorsforlymphnodemetastasisandperineuralinvasioninpancreaticcarcinoma
AT caicy upregulatedmatrixmetalloproteinase2anddownregulatedtissuefactorpathwayinhibitor2areriskfactorsforlymphnodemetastasisandperineuralinvasioninpancreaticcarcinoma
AT tangzg upregulatedmatrixmetalloproteinase2anddownregulatedtissuefactorpathwayinhibitor2areriskfactorsforlymphnodemetastasisandperineuralinvasioninpancreaticcarcinoma
_version_ 1725061161105227776